|
(11) | EP 1 411 920 A2 |
(12) |
|
|
|
|
|||||||||||||||||||||||
(54) | USE OF EPIGALLOCATECHIN-3-GALLATE OR DERIVATIVES THEREOF IN THE PROPHYLAXIS AND TREATMENT OF NEURODEGENERATIVE DISEASES |